See more : Paradise Co., Ltd. (034230.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Sequent Scientific Limited (SEQUENT.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sequent Scientific Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Gentian Diagnostics ASA (GENT.OL) Income Statement Analysis – Financial Results
- Winning Tower Group Holdings Limited (8362.HK) Income Statement Analysis – Financial Results
- Choice International Limited (CHOICEIN.NS) Income Statement Analysis – Financial Results
- Silver Tiger Metals Inc. (SLVR.V) Income Statement Analysis – Financial Results
- Fujian Kuncai Material Technology Co., Ltd. (603826.SS) Income Statement Analysis – Financial Results
Sequent Scientific Limited (SEQUENT.BO)
About Sequent Scientific Limited
Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.66B | 14.18B | 14.10B | 13.52B | 11.61B | 10.22B | 8.42B | 6.78B | 6.01B | 4.41B | 3.94B | 3.26B | 3.45B | 3.12B | 2.84B | 1.44B | 747.96M | 447.21M |
| Cost of Revenue | 8.13B | 8.99B | 8.44B | 7.37B | 6.38B | 5.74B | 4.83B | 3.77B | 3.38B | 2.59B | 2.44B | 2.12B | 2.14B | 1.74B | 1.28B | 665.45M | 545.58M | 303.64M |
| Gross Profit | 5.53B | 5.20B | 5.66B | 6.15B | 5.22B | 4.47B | 3.59B | 3.01B | 2.63B | 1.82B | 1.49B | 1.14B | 1.31B | 1.38B | 1.57B | 774.76M | 202.38M | 143.57M |
| Gross Profit Ratio | 40.49% | 36.65% | 40.12% | 45.52% | 44.99% | 43.77% | 42.62% | 44.40% | 43.77% | 41.20% | 37.95% | 34.97% | 37.92% | 44.30% | 55.12% | 53.79% | 27.06% | 32.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.85M | 124.50M | 88.56M | 96.87M | 115.37M | 65.82M | 0.00 | 0.00 | 0.00 | 0.00 | 12.80M | 4.69M |
| General & Administrative | 553.61M | 540.26M | 500.31M | 455.06M | 380.48M | 311.09M | 297.95M | 248.19M | 184.08M | 92.52M | 104.79M | 62.40M | 31.06M | 298.16M | 0.00 | 0.00 | 28.22M | 13.74M |
| Selling & Marketing | 285.88M | 281.33M | 276.76M | 217.38M | 237.79M | 141.34M | 177.85M | 144.56M | 68.93M | 115.38M | 55.98M | 42.72M | 41.44M | 0.00 | 0.00 | 0.00 | 22.54M | 5.97M |
| SG&A | 839.49M | 821.59M | 777.07M | 672.44M | 618.27M | 452.43M | 475.80M | 392.75M | 253.01M | 207.90M | 160.77M | 105.12M | 72.50M | 298.16M | 0.00 | 0.00 | 50.76M | 19.71M |
| Other Expenses | 4.69B | -123.49M | -51.74M | -30.79M | -83.07M | -60.99M | -44.18M | -105.21M | -59.69M | -2.59M | -36.33M | -24.76M | -11.06M | 238.02M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.53B | 5.19B | 4.98B | 4.40B | 3.76B | 3.44B | 2.98B | 2.69B | 2.40B | 1.79B | 1.51B | 1.35B | 987.59M | 3.02B | 956.40M | 850.65M | 141.55M | 29.20M |
| Cost & Expenses | 13.62B | 14.18B | 13.43B | 11.77B | 10.15B | 9.19B | 7.81B | 6.46B | 5.78B | 4.38B | 3.95B | 3.47B | 3.13B | 4.76B | 2.23B | 1.52B | 687.13M | 332.84M |
| Interest Income | 6.44M | 12.09M | 2.41M | 6.26M | 15.03M | 13.45M | 38.81M | 8.55M | 32.19M | 10.95M | 8.94M | 7.68M | 30.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 480.86M | 297.19M | 135.09M | 192.54M | 327.02M | 287.50M | 292.86M | 266.58M | 330.54M | 383.07M | 311.28M | 303.07M | 269.99M | 238.02M | 216.65M | 50.52M | 18.67M | 2.96M |
| Depreciation & Amortization | 615.40M | 556.93M | 510.85M | 505.98M | 506.22M | 419.20M | 413.43M | 400.73M | 462.20M | 329.35M | 325.97M | 286.07M | 229.81M | 187.93M | 239.10M | 64.79M | 29.98M | 13.79M |
| EBITDA | 549.80M | -464.48M | 1.20B | 2.12B | 1.80B | 1.34B | 980.57M | 540.22M | 638.77M | 114.11M | -382.81M | -106.97M | 475.58M | -1.45B | 850.70M | -11.10M | 85.73M | 126.57M |
| EBITDA Ratio | 4.02% | -0.61% | 8.38% | 15.90% | 16.06% | 12.65% | 11.81% | 10.98% | 10.09% | 6.90% | 4.28% | -2.59% | 11.16% | -46.60% | 29.91% | -0.77% | 11.46% | 28.66% |
| Operating Income | 370.21M | -97.37M | 355.94M | 1.55B | 1.07B | 826.17M | 412.83M | -14.22M | -187.14M | -684.22M | -1.10B | -727.50M | -62.75M | -1.64B | 611.60M | -75.89M | 55.75M | 114.37M |
| Operating Income Ratio | 2.71% | -0.69% | 2.52% | 11.46% | 9.26% | 8.09% | 4.90% | -0.21% | -3.11% | -15.53% | -27.93% | -22.31% | -1.82% | -52.62% | 21.50% | -5.27% | 7.45% | 25.57% |
| Total Other Income/Expenses | -916.67M | -1.11B | -50.32M | -321.28M | -517.41M | -237.33M | -369.64M | -325.61M | -313.28M | -527.66M | -1.04B | -270.90M | -343.82M | 1.68B | -216.65M | -50.52M | -23.75M | -2.95M |
| Income Before Tax | -546.46M | -1.38B | 529.30M | 1.37B | 940.75M | 588.84M | 236.45M | -143.91M | -153.97M | -633.19M | -1.10B | -727.50M | -54.13M | 34.89M | 394.95M | -126.41M | 37.08M | 111.42M |
| Income Before Tax Ratio | -4.00% | -9.71% | 3.75% | 10.11% | 8.11% | 5.76% | 2.81% | -2.12% | -2.56% | -14.37% | -27.87% | -22.31% | -1.57% | 1.12% | 13.88% | -8.78% | 4.96% | 24.91% |
| Income Tax Expense | -250.33M | -156.81M | 81.66M | 321.77M | 120.29M | 20.07M | 134.57M | -5.27M | 25.69M | 33.90M | 5.79M | -76.12M | -39.54M | 75.13M | 85.26M | 20.18M | 11.86M | 58.63M |
| Net Income | -358.69M | -1.21B | 409.55M | 954.42M | 699.05M | 486.60M | 4.22B | -138.24M | -184.69M | -107.37M | -1.10B | -646.94M | -13.99M | -1.76M | 374.17M | -146.59M | 25.22M | 85.75M |
| Net Income Ratio | -2.63% | -8.54% | 2.90% | 7.06% | 6.02% | 4.76% | 50.07% | -2.04% | -3.07% | -2.44% | -28.08% | -19.84% | -0.41% | -0.06% | 13.15% | -10.18% | 3.37% | 19.17% |
| EPS | -1.44 | -4.88 | 1.67 | 3.87 | 2.87 | 2.00 | 17.40 | -0.58 | -0.89 | -0.75 | -8.55 | -5.70 | -0.13 | -0.02 | 3.52 | -2.64 | 0.51 | 1.52 |
| EPS Diluted | -1.44 | -4.84 | 1.65 | 3.85 | 2.85 | 1.99 | 17.28 | -0.57 | -0.87 | -0.75 | -8.55 | -5.70 | -0.13 | -0.02 | 3.52 | -2.64 | 0.51 | 1.52 |
| Weighted Avg Shares Out | 249.09M | 248.47M | 247.41M | 246.88M | 243.44M | 242.79M | 242.29M | 239.31M | 208.49M | 143.08M | 129.19M | 113.48M | 109.68M | 109.68M | 106.18M | 55.43M | 49.00M | 33.33M |
| Weighted Avg Shares Out (Dil) | 249.09M | 250.11M | 250.73M | 247.87M | 245.31M | 243.99M | 243.94M | 241.00M | 212.17M | 143.08M | 129.19M | 113.48M | 109.68M | 109.68M | 106.18M | 55.43M | 49.00M | 33.33M |
Source: https://incomestatements.info
Category: Stock Reports